Last Updated: September 28, 2026

Details for New Drug Application (NDA): 202470

✉ Email this page to a colleague

« Back to Dashboard

NDA 202470 describes DESONIDE, which is a drug marketed by Alembic, Cadila, Cosette Pharms Nc, Glenmark Speclt, Padagis Us, Sun Pharma Canada, Senores Pharms, Encube, Fougera Pharms, Taro, Encube Ethicals, Glenmark Pharms Ltd, Hikma, and Pai Holdings Pharm, and is included in twenty NDAs. It is available from thirteen suppliers. Additional details are available on the DESONIDE profile page.

The generic ingredient in DESONIDE is desonide. There is one drug master file entry for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the desonide profile page.

Summary for 202470

Tradename:	DESONIDE
Applicant:	Senores Pharms
Ingredient:	desonide
Patents:	0

Pharmacology for NDA: 202470

Mechanism of Action	Corticosteroid Hormone Receptor Agonists

Medical Subject Heading (MeSH) Categories for 202470

Anti-Inflammatory Agents

Suppliers and Packaging for NDA: 202470

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
DESONIDE	desonide	GEL;TOPICAL	202470	ANDA	Cintex Services, LLC	24470-920	24470-920-60	1 TUBE in 1 CARTON (24470-920-60) / 60 g in 1 TUBE

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	GEL;TOPICAL			Strength	0.05%
Approval Date:	May 11, 2020	TE:		RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.